Marianne Stanford - From Cancer to COVID19 Science to Business Network (S2BN) Podcast
-
- Science
Marianne Stanford, PhD, shares her career path that led to joining IMV Inc, a Halifax-based biotech company, almost 10 years ago. She also describes IMV's efforts to leverage their cancer immunotherapy technology and expertise towards developing an effective COVID19 vaccine.
Dr. Stanford is current Vice-President, Research and Development at IMV Inc, a Halifax based biotechnology company overseeing all preclinical research activities and clinical immunology assessment of cancer immunotherapies and infectious disease vaccines. She received her BSc and MSc from Memorial University of Newfoundland and her PhD from Dalhousie University. She performed post-doctoral research with Dr. Grant McFadden at Western University (London, Ontario) and Dr. John Bell at Ottawa Hospital Research Institute.
Marianne Stanford, PhD, shares her career path that led to joining IMV Inc, a Halifax-based biotech company, almost 10 years ago. She also describes IMV's efforts to leverage their cancer immunotherapy technology and expertise towards developing an effective COVID19 vaccine.
Dr. Stanford is current Vice-President, Research and Development at IMV Inc, a Halifax based biotechnology company overseeing all preclinical research activities and clinical immunology assessment of cancer immunotherapies and infectious disease vaccines. She received her BSc and MSc from Memorial University of Newfoundland and her PhD from Dalhousie University. She performed post-doctoral research with Dr. Grant McFadden at Western University (London, Ontario) and Dr. John Bell at Ottawa Hospital Research Institute.
45 min